|
1
|
Hsu YH, Venners SA, Terwedow HA, et al:
Relation of body composition, fat mass and serum lipids to
osteoporotic fractures and bone mineral density in Chinese men and
women. Am J Clin Nutr. 83:146–154. 2006.PubMed/NCBI
|
|
2
|
Zhao LJ, Jiang H, Papasian CJ, et al:
Correlation of obesity and osteoporosis: Effect of fat mass on the
determination of osteoporosis. J Bone Miner Res. 23:17–29. 2008.
View Article : Google Scholar
|
|
3
|
Cao JJ, Gregoire BR and Gao H: High-fat
diet decreases cancellous bone mass but has no effect on cortical
bone mass in the tibia in mice. Bone. 44:1097–1104. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fehrendt H, Linn T, Hartmann S, et al:
Negative influence of a long-term high-fat diet on murine bone
architecture. Int J Endocrinol. 2014:3189242014.PubMed/NCBI
|
|
5
|
Kyung TW, Lee JE, Phan TV, Yu R and Choi
HS: Osteoclastogenesis by bone marrow-derived macrophages is
enhanced in obese mice. J Nutr. 139:502–506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Halade GV, Rahman MM, Williams PJ and
Fernandes G: High fat diet-induced animal model of age-associated
obesity and osteoporosis. J Nutr Biochem. 21:1162–1169. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patsch JM, Kiefer FW, Varga P, et al:
Increased bone resorption and impaired bone microarchitecture in
short-term and extended high-fat diet-induced obesity. Metabolism.
60:243–249. 2011. View Article : Google Scholar
|
|
8
|
Baek K, Hwang HR, Park HJ, et al: TNF-α
upregulates sclerostin expression in obese mice fed a high-fat
diet. J Cell Physiol. 229:640–650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao Y, Cui J, Shi YH, Sun J, Wang ZP and
Le GW: Effects of duodenal redox status on calcium absorption and
related genes expression in high-fat diet-fed mice. Nutrition.
26:1188–1194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen JR, Lazarenko OP, Wu X, et al:
Obesity reduces bone density associated with activation of PPARγ
and suppression of Wnt/β-catenin in rapidly growing male rats. PLoS
One. 5:e137042010. View Article : Google Scholar
|
|
11
|
Kawano K, Hirashima T, Mori S, Saitoh Y,
Kurosumi M and Natori T: Spontaneous long-term hyperglycemic rat
with diabetic complications. Otsuka Long-Evans Tokushima Fatty
(OLETF) strain. Diabetes. 41:1422–1428. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawano K, Hirashima T, Mori S and Natori
T: OLETF (Otsuka Long-Evans Tokushima Fatty) rat: A new NIDDM rat
strain. Diabetes Res Clin Pract. (Suppl 24): S317–S320. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moran TH and Bi S: Hyperphagia and obesity
of OLETF rats lacking CCK1 receptors: Developmental aspects. Dev
Psychobiol. 48:360–367. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gibbs J, Young RC and Smith GP:
Cholecystokinin elicits satiety in rats with open gastric fistulas.
Nature. 245:323–325. 1973. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schroeder M, Zagoory-Sharon O, Shbiro L,
et al: Development of obesity in the Otsuka Long-Evans Tokushima
Fatty rat. Am J Physiol Regul Integr Comp Physiol. 297:R1749–R1760.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bi S, Ladenheim EE, Schwartz GJ and Moran
TH: A role for NPY overexpression in the dorsomedial hypothalamus
in hyperphagia and obesity of OLETF rats. Am J Physiol Regul Integr
Comp Physiol. 281:R254–R260. 2001.PubMed/NCBI
|
|
17
|
Man ZW, Hirashima T, Mori S and Kawano K:
Decrease in triglyceride accumulation in tissues by restricted diet
and improvement of diabetes in Otsuka Long-Evans Tokushima fatty
rats, a non-insulin-dependent diabetes model. Metabolism.
49:108–114. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park SY, Choi GH, Choi HI, Ryu J, Jung CY
and Lee W: Calorie restriction improves whole-body glucose disposal
and insulin resistance in association with the increased
adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima
fatty rats. Arch Biochem Biophys. 436:276–284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bajotto G, Murakami T, Nagasaki M, et al:
Downregulation of the skeletal muscle pyruvate dehydrogenase
complex in the Otsuka Long-Evans Tokushima Fatty rat both before
and after the onset of diabetes mellitus. Life Sci. 75:2117–2130.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Laye MJ, Rector RS, Warner SO, et al:
Changes in visceral adipose tissue mitochondrial content with type
2 diabetes and daily voluntary wheel running in OLETF rats. J
Physiol. 587:3729–3739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Omi N, Nakamura T and Ezawa I: Modulation
of bone mass and turnover in growing rats by voluntary
weight-bearing exercise and glucose supplementation. J Nutr Sci
Vitaminol (Tokyo). 44:409–421. 1998. View Article : Google Scholar
|
|
22
|
Hie M, Shimono M, Fujii K and Tsukamoto I:
Increased cathepsin K and tartrate-resistant acid phosphatase
expression in bone of streptozotocin-induced diabetic rats. Bone.
41:1045–1050. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bergman I and Loxley R: The determination
of hydroxyproline in urine hydrolysates. Clin Chim Acta.
27:347–349. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goto A and Tsukamoto I: Increase in
tartrate-resistant acid phosphatase of bone at the early stage of
ascorbic acid deficiency in the ascorbate-requiring Osteogenic
Disorder Shionogi (ODS) rat. Calcif Tissue Int. 73:180–185. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Parfitt AM, Drezner MK, Glorieux FH, et
al: Bone histomorphometry: Standardization of nomenclature, symbols
and units. Report of the ASBMR Histomorphometry Nomenclature
Committee. J Bone Miner Res. 2:595–610. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Hie M, Yamazaki M and Tsukamoto I:
Curcumin suppresses increased bone resorption by inhibiting
osteoclastogenesis in rats with streptozotocin-induced diabetes.
Eur J Pharmacol. 621:1–9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sato T, Shibata T, Ikeda K and Watanabe K:
Generation of bone-resorbing osteoclasts from B220+ cells: its role
in accelerated osteoclastogenesis due to estrogen deficiency. J
Bone Miner Res. 16:2215–2221. 2001. View Article : Google Scholar
|
|
29
|
Hie M, Iitsuka N, Otsuka T, Nakanishi A
and Tsukamoto I: Zinc deficiency decreases osteoblasts and
osteoclasts associated with the reduced expression of Runx2 and
RANK. Bone. 49:1152–1159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hie M and Tsukamoto I: Increased
expression of the receptor for activation of NF-κB and decreased
runt-related transcription factor 2 expression in bone of rats with
streptozotocin-induced diabetes. Int J Mol Med. 26:611–618.
2010.PubMed/NCBI
|
|
31
|
Hayashi S, Miyamoto A, Yamane T, et al:
Osteoclast precursors in bone marrow and peritoneal cavity. J Cell
Physiol. 170:241–247. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Manolagas SC: Birth and death of bone
cells: Basic regulatory mechanisms and implications for the
pathogenesis and treatment of osteoporosis. Endocr Rev. 21:115–137.
2000.PubMed/NCBI
|
|
33
|
Suda T, Takahashi N, Udagawa N, Jimi E,
Gillespie MT and Martin TJ: Modulation of osteoclast
differentiation and function by the new members of the tumor
necrosis factor receptor and ligand families. Endocr Rev.
20:345–357. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Riggs BL: The mechanisms of estrogen
regulation of bone resorption. J Clin Invest. 106:1203–1204. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hofbauer LC, Khosla S, Dunstan CR, Lacey
DL, Boyle WJ and Riggs BL: The roles of osteoprotegerin and
osteoprotegerin ligand in the paracrine regulation of bone
resorption. J Bone Miner Res. 15:2–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Arai F, Miyamoto T, Ohneda O, et al:
Commitment and differentiation of osteoclast precursor cells by the
sequential expression of c-Fms and receptor activator of nuclear
factor kappaB (RANK) receptors. J Exp Med. 190:1741–1754. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ishii J, Kitazawa R, Mori K, et al:
Lipopolysaccharide suppresses RANK gene expression in macrophages
by down-regulating PU.1 and MITF. J Cell Biochem. 105:896–904.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang DE, Hetherington CJ, Chen HM and
Tenen DG: The macrophage transcription factor PU.1 directs
tissue-specific expression of the macrophage colony-stimulating
factor receptor. Mol Cell Biol. 14:373–381. 1994.PubMed/NCBI
|
|
39
|
Yao Z, Li P, Zhang Q, et al: Tumor
necrosis factor-alpha increases circulating osteoclast precursor
numbers by promoting their proliferation and differentiation in the
bone marrow through up-regulation of c-Fms expression. J Biol Chem.
281:11846–11855. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Manolagas SC, Kousteni S and Jilka RL: Sex
steroids and bone. Recent Prog Horm Res. 57:385–409. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fujita D, Yamashita N, Iita S, Amano H,
Yamada S and Sakamoto K: Prostaglandin E2 induced the
differentiation of osteoclasts in mouse osteoblast-depleted bone
marrow cells. Prostaglandins Leukot Essent Fatty Acids. 68:351–358.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Singer P, Shapiro H, Theilla M, Anbar R,
Singer J and Cohen J: Anti-inflammatory properties of omega-3 fatty
acids in critical illness: Novel mechanisms and an integrative
perspective. Intensive Care Med. 34:1580–1592. 2008. View Article : Google Scholar : PubMed/NCBI
|
